This article was originally published in The Tan Sheet
Bernard Schachtel, MD, Department of Epidemiology & Public Health, Yale University School of Medicine, has been appointed Vice Chair of the Drug Development & Regulatory (DDR) Science Section of the American Society for Clinical Pharmacology & Therapeutics. DDR is the largest section in the Society, with activities encompassing U.S. and worldwide governmental regulations as well as issues affecting the development of pharmaceuticals, nonprescription drugs, nutritional supplements and medical devices. Schachtel also serves as Medical Director of Schachtel Research Company, Jupiter, Fla...
You may also be interested in...
“There’s a heightened need for products that deliver against health, hygiene and clean home concerns and a willingness to spend just a little bit more to ensure that I’m using a product that I know and trust,” says CFO Jon Moeller
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
The COVID-19 pandemic continues to drive innovation in robotics to provide care and comfort at a safe distance.